Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins

26 Jun 2021

Abstract excerpt

The immunogenicity of the SARS-CoV-2 proteome is largely unknown, especially for non-structural proteins and accessory proteins. In this study, we collect 2,360 COVID-19 sera and 601 control sera. We analyze these sera on a protein microarray with 20 proteins of SARS-CoV-2, building an antibody response landscape for immunoglobulin (Ig)G and IgM. Non-structural proteins and accessory proteins NSP1, NSP7, NSP8,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to SARS-CoV-2 detection and testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34242574
DOI: 10.1016/j.celrep.2021.109391

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteinsPMID 34242574Read ↗

SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responsesSemantic proximity Read ↗

The Dynamic Changes of Antibodies against SARS-CoV-2 during the Infection and Recovery of COVID-19Semantic proximity Read ↗

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes.Semantic proximity Read ↗

SARS-CoV-2 antibody responses determine disease severity in COVID-19 infected individualsSemantic proximity Read ↗

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes in COVID-19 convalescent plasmaSemantic proximity Read ↗

Deciphering the IgG Idiotype Network Through Proteomic Analysis of Potential Targets in SARS ‐ CoV ‐2‐Induced Immune ResponsesSemantic proximity Read ↗

SARS-CoV-2 multi-antigen protein microarray for detailed characterization of antibody responses in COVID-19 patientsSemantic proximity Read ↗

The landscape of antibody binding in SARS-CoV-2 infectionSemantic proximity Read ↗

Investigation of Immunoreactivity Profiles and Epitope Landscape in Divergent COVID-19 Trajectories and SARS-CoV-2 Variants.Semantic proximity Read ↗

High-Specificity Targets in SARS-CoV-2 N Protein for Serological Antibody DetectionSemantic proximity Read ↗

SARS-CoV-2 ORF8: One protein, seemingly one structure, and many functionsSemantic proximity Read ↗

Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelaeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.